Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00903734
What this trial is testing

An Umbrella, Modular Study Based on Epidermal Growth Factor Receptor (EGFR) Mutation Status

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05607004
What this trial is testing

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Who this might be right for
Breast NeoplasmsInvasive Breast CancerEstrogen-receptor-positive Breast Cancer+1 more
Atossa Therapeutics, Inc. 87
Not applicableStudy completedNCT05912933
What this trial is testing

Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Function) in Breast Cancer Patients Treated With the Study Medicine Palbociclib (Pal-bow-sai-klib)

Who this might be right for
Breast Cancer
Pfizer 1,342
Testing effectiveness (Phase 2)Study completedNCT01719549
What this trial is testing

Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1

Who this might be right for
Gastric Cancer
Asan Medical Center 19
Testing effectiveness (Phase 2)Study completedNCT00940316
What this trial is testing

Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Northwestern University 28
Large-scale testing (Phase 3)Ended earlyNCT02186301
What this trial is testing

TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Clovis Oncology, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT03160781
What this trial is testing

Intraosseous PRP for Knee Osteoarthritis: Pilot Study

Who this might be right for
Knee Osteoarthritis
Unidad de Cirugía Artroscópica 19
Testing effectiveness (Phase 2)WithdrawnNCT02846766
What this trial is testing

Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling

Who this might be right for
Cancer
Teresa Helsten, MD
Testing effectiveness (Phase 2)UnknownNCT02340845
What this trial is testing

Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans

Who this might be right for
Cancer
Oeyama-Moto Cancer Research Foundation 100
Not applicableStudy completedNCT04012983
What this trial is testing

Possible Role of Gingival Crevicular Fluid Levels of Chemerin and Fibroblast Growth Factor 21 as Biomarkers of Periodontal Disease in Diabetic and Non-diabetic Patients

Who this might be right for
Periodontal Disease (Diagnosis)Diabetes Mellitus, Type 2
Cairo University 45
Not applicableStudy completedNCT02930356
What this trial is testing

Effect of Tooth Cleaning in Smokers and Non Smokers With Gum Disease.

Who this might be right for
Chronic Periodontitis
Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre 40
Testing effectiveness (Phase 2)Study completedNCT02636270
What this trial is testing

IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency

Who this might be right for
Short Stature
Children's Hospital Medical Center, Cincinnati 7
Not applicableStudy completedNCT02750956
What this trial is testing

Endocan, VEGF and TNF-alpha Levels in Periodontal Disease and After Treatment

Who this might be right for
Periodontal Disease
Bulent Ecevit University 40
Early research (Phase 1)Study completedNCT01046266
What this trial is testing

Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Hoffmann-La Roche 62
Not applicableStudy completedNCT02913456
What this trial is testing

A European Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced (LA) or Metastatic Breast Cancer (mBC) (SAMANTHA)

Who this might be right for
Breast Cancer
Hoffmann-La Roche 629
Testing effectiveness (Phase 2)Ended earlyNCT00807612
What this trial is testing

QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Advanced Squamous Non-Small Cell Lung Cancer
NantCell, Inc. 15
Not applicableUnknownNCT05938907
What this trial is testing

Effect of Concentrated Growth Factors on Healing of Apicomarginal Defects: a Prospective Study

Who this might be right for
Concentrated Growth FactorBone Substitute
West China Hospital 72
Not applicableStudy completedNCT01588093
What this trial is testing

IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I Concentrations

Who this might be right for
Type 1 Diabetes Mellitus
Peter Bang 8
Early research (Phase 1)Active Not RecruitingNCT04844619
What this trial is testing

KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial

Who this might be right for
Neovascular GlaucomaNeovascularization
Sun Yat-sen University 40
Not applicableStudy completedNCT04076787
What this trial is testing

Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 1,769
Next Page